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Unrestrained 53BP1 activity at DNA double-strand breaks (DSBs)
hampers DNA end resection and upsets DSB repair pathway choice.
RNF169 acts as a molecular rheostat to limit 53BP1 deposition at DSBs,
but how this fine balance translates to DSB repair control remains
undefined. In striking contrast to 53BP1, ChIP analyses of AsiSI-
induced DSBs unveiled that RNF169 exhibits robust accumulation at
DNA end-proximal regions and preferentially targets resected, RPA-
bound DSBs. Accordingly, we found that RNF169 promotes CtIP-
dependent DSB resection and favors homology-mediated DSB repair,
and further showed that RNF169 dose-dependently stimulates single-
strand annealing repair, in part, by alleviating the 53BP1-imposed
barrier to DSB end resection. Our results highlight the interplay of
RNF169 with 53BP1 in fine-tuning choice of DSB repair pathways.
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DNA double-strand breaks (DSBs) pose serious threats togenome integrity and cell viability. Unrepaired DSBs not
only perturb gene expression programs but can fuel chromosome
translocation and chromosome missegregation (1–3), leading to
permanent cell arrest, premature cell senescence, and cell death
(4). To mend broken DNA in a timely manner, cells deploy mul-
tiple DSB repair pathways, namely classical nonhomologous end
joining (cNHEJ), alternative nonhomologous end joining (aNHEJ),
homologous recombination (HR), and single-strand annealing
(SSA) (5, 6), to suppress the otherwise deleterious effects of per-
sistent DSBs in cell proliferation and animal development.
cNHEJ represents the predominant DSB repair pathway in
mammalian cells, involves no or limited DNA end processing,
and does not require sequence homology (7). During cNHEJ,
DNA ends are bound by the Ku70/Ku80 complex (Ku) to pre-
vent end resection by nucleases (8). The Ku complex serves as a
platform for docking additional NHEJ factors including DNA-
PKcs, Artemis, DNA Ligase IV, XRCC4, XLF, and PAXX. By
contrast, the aNHEJ, HR, and SSA repair pathways favor
resected DSB intermediates that bear 3′ single-strand DNA
(ssDNA) overhangs (9). DNA end resection entails the co-
ordinated nucleolytic degradation of 5′ DNA strands and is ex-
ecuted by a cohort of nucleolytic and DNA unwinding activities
(10). The mammalian MRE11-RAD50-NBS1 (MRN)/CtIP
complex plays an initiating role in DNA end resection and ex-
poses short 3′ ssDNA tails. At this stage, aNHEJ machineries
can rejoin broken DSB ends by annealing two ssDNA overhangs
that carry microhomologies. Key components of aNHEJ include
PARP-1, DNA Ligase III, and DNA polymerase θ. Further DSB
processing by EXO1, DNA2, and BLM results in extensively
resected ssDNAs that prime HR and SSA repair. HR repair is
activated strictly in S and G2 phases of the cell cycle when sister
chromatids are available and is considered an error-free repair
pathway. In an HR reaction, the RAD51 recombinase nucleates
onto ssDNAs at resected DSBs to form nucleoprotein filaments
that catalyze homology search and strand invasion events. SSA,
however, is adapted to repair DSBs at genomic loci bearing re-
petitive DNA sequences. The SSA machineries appear to be
evolutionarily conserved (11–13) and require extensive DNA end
resection to reveal flanking homologous sequence. SSA ensues
when the DNA annealing factor RAD52 coats ssDNA overhangs
and mediates annealing of DNA molecules that bear homology
(14). The nonhomologous 3′ ssDNA tails at the synapsed in-
termediate are subsequently processed by the ERCC1/XPF en-
donuclease, and the gaps generated are filled and sealed by
uncharacterized DNA polymerase(s) and DNA ligase(s) (5, 15).
Notably, SSA is generally considered mutagenic as it is associ-
ated with loss of DNA repeats. Notably, aside from the extent of
DNA end resection at DSBs, activation and engagement of the
mechanistically distinct DSB repair pathways can be influenced
by cell cycle phase, DSB chromosomal location, and preexisting
epigenetic marks at the DSB landscape (16–18).
53BP1 mediates NHEJ events and is pivotal in programmed
DSBs repair, including long-range V(D)J recombination and
class-switch recombination (19, 20). 53BP1 is recruited to DSB-
flanking chromatin via multivalent interactions involving
H2AK15ub (21), H4K20me2 (22), and the nucleosome acidic
patch (23), where it has been proposed to protect DSBs from
DNA end processing, thereby antagonizing HR and SSA. As
such, 53BP1 and its downstream effectors RIF1 (24–28), PTIP
(29), REV7/MAD2L2 (30, 31), and Shieldin/FAM35A (32, 33)
act in concerted efforts to tilt the balance of DSB repair pathway
choice in favor of NHEJ. Indeed, unrestrained 53BP1 activities
are associated with telomeric fusions and toxic NHEJ repair
products (34). Interestingly, not only does 53BP1 inactivation
restore HR and contribute to resistance to PARP inhibitors in
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BRCA cancer cells (35–37), but 53BP1 nullizygocity rescues
embryonic lethality of BRCA1-deficient animals (38), high-
lighting the interplay of 53BP1 and BRCA proteins in DSB re-
pair control. Recent evidence also implicates a role of 53BP1 in
allowing limited DSB resection to foster high-fidelity HR over mu-
tagenic SSA repair (39). Another branch of HR-inhibiting activities is
encoded by the RAP80–BRCA1 complex, which accumulates at the
DSB-flanking chromatin by recognizing RNF8/RNF168-catalyzed
K63-linked ubiquitin structures (40), and is antagonized by
ZMYM3 (41). In reminiscence to 53BP1, RAP80 docking at DSBs
correlates with inhibited DSB resection (42, 43), and RAP80 silencing
results in hyperactive HR and SSA (41, 43–46).
The Ring Finger protein RNF169 is emerging as a molecular
rheostat that limits 53BP1 and RAP80 deposition at the
ubiquitin-modified DSB-flanking chromatin to drive high-fidelity
HR repair (47–50). While elegant structural studies have un-
veiled the mechanistic bases that underlie the functional com-
petition between 53BP1 and RNF169 at DSBs (23, 51, 52),
exactly how this fine balance is coupled to the choice of DSB
repair pathways remains to be established.
Results
RNF169 Limits 53BP1 and RAP80 Deposition at AsiSI-Induced DSBs.
RNF169 suppresses the loading of DNA damage mediator
proteins 53BP1 and RAP80 at ionizing radiation-induced foci
(IRIF) (47–49). The fact that a subset of RNF169-overexpressing
cells still supported formation of 53BP1 IRIF (SI Appendix, Fig.
S1A) suggests that RNF169 and 53BP1 may cooccupy DSB-
flanking chromatin domains. Analysis of endogenous RNF169
and 53BP1 in IR-treated HeLa cells confirmed that both DNA
damage response (DDR) proteins coexist at IRIF (SI Appendix,
Fig. S1B). To illuminate the spatial distribution of RNF169 and
53BP1 at IRIF, we visualized IRIF in U2OS cells engineered to
stably express Flag epitope-tagged RNF169 using superresolution
structured illumination microscopy (SR-SIM). Anti-Flag anti-
bodies (M2) were used in place of anti-RNF169 antibodies be-
cause the former allowed better visualization of RNF169
subcellular localization. Notably, cells that stably express Flag
epitope-tagged RNF169 supported the formation of 53BP1 foci
following IR treatment at frequencies similar to parental U2OS
cells (>95%). Accordingly, we found that Flag-RNF169 and
53BP1 were oriented in juxtaposition to each other (SI Appen-
dix, Fig. S1C), supporting the idea that the competing activities
may occupy different chromatin domains surrounding DSBs.
To better dissect how RNF169 and 53BP1 are distributed along
the DSB-flanking chromatin, we took advantage of the DIvA
(DSB-induced via AsiSI) platform, wherein DSBs can be induced
at AsiSI-target sequence across the human genome (53, 54).
Pretreatment of AsiSI-ER-U2OS cells with 4-hydroxy tamoxifen
(4-OHT) triggers the nuclear translocation of the AsiSI endonu-
clease and results in 100–200 site-specific DSBs (Fig. 1A). To
study how RNF169 may serve as a molecular rheostat to modulate
the deposition of 53BP1 and other DDR factors at DSBs, we also
assembled a doxycycline (Dox)-inducible RNF169 expression
cassette, and stably integrated it into AsiSI-ER-U2OS cells
(hereafter referred to as DIvA-eRNF169; Fig. 1A). We first
validated that the antagonistic effects of RNF169 on 53BP1 and
RAP80 accumulation at IRIFs can be recapitulated at AsiSI-
induced DSBs by indirect immunofluorescence staining experi-
ments using in-house antibodies described previously (48, 50).
Accordingly, ectopic expression of RNF169 (eRNF169) led to
marked reduction of 53BP1 and RAP80 foci at AsiSI-induced
DSBs (SI Appendix, Fig. S2 A and B) and did not noticeably
affect γH2AX foci formation (SI Appendix, Fig. S2C). RNF169 is
targeted to DSBs via its ubiquitin-binding MIU2 domain where
it displaces 53BP1 and RAP80 (47–49, 52). Consistent with the
requirement of RNF169 MIU2 in antagonizing 53BP1 docking
at DSBs, 53BP1 foci number and intensity were indistinguish-
able in cells expressing an RNF169 MIU2-deletion mutant
(eRNF169ΔMIU2) compared with mock-treated cells (SI Ap-
pendix, Fig. S2D). To explore whether the RNF169-encoded
inhibitory effect on 53BP1 deposition at AsiSI-induced DSBs
may be regulated in a cell cycle-dependent manner, we syn-
chronized DIvA-eRNF169 cells at different cell cycle phases
and quantified 53BP1 foci-positive cells following AsiSI in-
duction. Because ectopic expression of RNF169 efficiently
suppressed 53BP1 foci in all cell populations (SI Appendix, Fig.
S2 E and F), we concluded that RNF169 is proficient in lim-
iting 53BP1 deposition at AsiSI-induced DSBs in a cell cycle-
independent manner.
Spatial Distribution of RNF169 and 53BP1 at AsiSI-Induced DSBs.
While RNF169 and 53BP1 competes for binding to ubiquity-
lated nucleosomes in vitro (51, 52) and to RNF168-modified
chromatin in vivo (47–49), the opposing activities can be ob-
served at individual IRIF (SI Appendix, Fig. S1 B and C), sug-
gesting that RNF169 and 53BP1 may cooccupy DSB-flanking
chromatin. To best recapitulate the dynamic equilibrium of
RNF169 with 53BP1 and other DDR factors at DSBs, we titrated
in reducing concentrations of doxycycline such that eRNF169
may be expressed at near endogenous levels in DIvA-eRNF169
cells. We envisage that under such circumstances eRNF169 and
53BP1 may coexist at AsiSI-induced DSBs. Indeed, we found an
inverse relationship between dose of doxycycline (eRNF169 ex-
pression) and percentage of 53BP1 foci-positive cells, in line with
the competitive nature of RNF169 and 53BP1 occupancy at
DSBs (SI Appendix, Fig. S3 A and B). Importantly, immunolab-
eling studies performed in DIvA-eRNF169 cells pretreated with
0.02 μg/mL doxycycline revealed coexistence of eRNF169 with
γH2AX, 53BP1, and RAP80 at AsiSI-induced DSBs (SI Ap-
pendix, Fig. S3 C–E). Doxycycline-treated DIvA-eRNF169 cells
were subsequently processed to determine the subcellular lo-
calization of eRNF169 and its relationship with 53BP1 and
RAP80 at AsiSI-induced DNA damage foci using SR-SIM.
Consistent with those observed at IRIF (SI Appendix, Fig. S1C),
we found that eRNF169 and 53BP1 were often oriented in jux-
taposition at AsiSI-induced DNA damage foci (Fig. 1B). By
contrast, eRNF169 overlapped extensively with RAP80 (Fig.
1C). The differential occupancy of RNF169 and 53BP1 at
AsiSI-induced DSBs was also similarly observed when DIvA-
eRNF169 cells were imaged using stochastic optical recon-
struction microscopy (STORM; Fig. 1D). Together, these re-
sults suggest that RNF169 and 53BP1 may occupy distinct
chromatin territories at DSBs.
To test the possibility that RNF169 and 53BP1 may occupy
distinct DSB-flanking chromatin domains, we performed chro-
matin immunoprecipitation (ChIP) experimentations to profile
the distribution of eRNF169 and a panel of DDR factors at two
previously characterized AsiSI-induced DSBs on Chromosome 1
(i.e., Chr1_6 and Chr1_12) (53) (Fig. 1E). Specifically, we de-
termined DDR protein deposition on one side of chromatin
(0.1 kb to 2 Mb) flanking each of the two AsiSI sites. We used
previously validated ChIP grade anti-Flag (M2), anti-γH2AX,
and anti-53BP1 antibodies (55–57) and our in-house anti-
RAP80 antibodies (SI Appendix, Fig. S4 A and B). Accordingly,
treatment of DIvA-eRNF169 cells with 4-OHT led to substantial
enrichment of γH2AX, 53BP1, and RAP80 at both DSBs com-
pared with control cells (Fig. 1F and SI Appendix, Fig. S5A).
Enrichment of γH2AX was detectable to as far as 1 Mb away
from each of the AsiSI sites (Fig. 1F and SI Appendix, Fig. S5A),
results which are in line with previous ChIP-sequencing (ChIP-
Seq) data that documented megabase spreading of γH2AX along
DSB-flanking chromatin (53). Interestingly, whereas the 53BP1
profile along the AsiSI-induced DSB chromatin was similar to
that of γH2AX (Fig. 1F and SI Appendix, Fig. S5A), it contrasted
with that of RAP80, which preferentially accumulated at DNA
end-proximal regions (Fig. 1F and SI Appendix, Fig. S5A).
Notably, the inhibitory effects of RNF169 on 53BP1 and
RAP80 accumulation at AsiSI-induced DSBs observed by indirect
immunofluorescence staining experiments (SI Appendix, Fig. S2 A
and B) can be recapitulated in DIvA-eRNF169 cells pretreated
with a high dose of doxycycline (SI Appendix, Fig. S5A). Indeed,






ChIP-qPCR analyses revealed that ectopic expression of RNF169
compromised loading of 53BP1, and to a lesser extent RAP80,
onto the damaged chromatin (SI Appendix, Fig. S5A). Intriguingly,
eRNF169 displayed robust accumulation at DNA end-proximal
regions (SI Appendix, Fig. S5A). However, eRNF169 lacking its
MIU2 did not accumulate at AsiSI-induced DSBs and did not
noticeably affect 53BP1 distribution at the DSB-flanking chro-
matin (SI Appendix, Fig. S5B), consistent with the requirement of
RNF169 MIU2 in its targeting to DSBs (47–49). Importantly,
RNF169 inactivation reproducibly led to increase of 53BP1 de-
position, but not that of RAP80, at each of the two AsiSI-induced
DSBs (SI Appendix, Fig. S6 A and B). Together, these results
validate the DIvA-eRNF169 cells as a feasible model to study the
competitive relationships of RNF169 with 53BP1 at DSBs.
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Fig. 1. Spatial distribution of RNF169 and other DDR factors at DSBs. (A) Schematic illustration of the DIvA platform integrated with a doxycycline (Dox)-
inducible RNF169 expression cassette. (B and C) Representative SR-SIM images reveals the juxtaposed orientation of eRNF169 and 53BP1 (B) and colocalization
of eRNF169 and RAP80 (C) at AsiSI-induced DSBs. DIvA-eRNF169 cells were treated with 0.02 μg/mL doxycycline for 24 h, and 4-OHT was added 4 h before
immunostaining experiments using indicated antibodies. (D) Representative STORM image shows the juxtaposition of eRNF169 and 53BP1 at AsiSI-induced
DSBs. (E) Schematic illustration of the two AsiSI sites (Chr1_6 and Chr1_12) on Chromosome 1 used for ChIP-qPCR analysis. Each arrow represents a pair of
primers employed for qPCR analysis. (F) ChIP-qPCR analysis of distribution of γH2AX, 53BP1, RAP80, and eRNF169 on one side of chromatin flanking each of
the two AsiSI-induced DSBs. DIvA-eRNF169 cells were treated with or without 0.02 μg/mL doxycycline for 24 h, and 4-OHT was added 4 h before cells were
processed for ChIP experiments using indicated antibodies. Data represents mean ± SEM (of two technical repeats) derived from one representative ex-
periment (n = 3); (G) Graphical illustration of DSB spatial distribution of DDR factors characterized in this study. (Scale bars: 0.5 μm.)
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We next pretreated DIvA-eRNF169 cells with a low dose of
doxycycline to examine how RNF169 may cooccupy with 53BP1
and RAP80 at AsiSI-induced DSBs. At 0.02 μg/mL doxycycline,
spatial distributions of γH2AX, 53BP1, and RAP80 at DSB-
flanking chromatin were indistinguishable to that of control
(Fig. 1F). Notably, we found that eRNF169 was enriched at
proximal chromatin regions flanking each of the AsiSI target sites
(Fig. 1F), indicating that expression level change of RNF169 did
not detectably affect its DSB chromatin distribution (SI Appendix,
Fig. S5A). Because RNF169 promotes HR repair (47, 50),
prompted by the possibility that its accumulation may reflect its
functional role in driving high-fidelity DSB repair, we analyzed
and compared the enrichments of CtIP, RPA-1, and RAD51 at
AsiSI-induced DSBs. Consistent with their established roles in
early events in HR repair, namely DSB end resection and coating
of single-strand DNA (ssDNA) overhangs, we found that CtIP,
RPA-1, and RAD51 proteins were mostly deposited at DNA end-
proximal chromatin regions (SI Appendix, Fig. S7). Together, our
ChIP analyses of deposition of DDR factors at AsiSI-induced
DSBs uncovered that RNF169 and 53BP1 exhibit dissimilar dis-
tribution along the damaged chromatin domains (Fig. 1G) and led
us to speculate that the DSB-proximal docking of RNF169 may be
important in determining choice of DSB repair pathways.
Preferential Accumulation of RNF169 at HR-Prone DSBs. Because
RNF169 promotes HR repair (47, 50), we next asked whether
RNF169 may preferentially accumulate at HR-prone DSBs by
examining RNF169 deposition at RAD51-bound DSBs (DSB
IV–VI) and RAD51-unbound DSBs (DSB 1–3) as previously
reported (54). We confirmed the preferential deposition of the
HR factors RAD51 and RPA-1 at HR-prone DSBs, whereas
γH2AX enrichment at both RAD51-bound and RAD51-unbound
DSBs were similar (Fig. 2A). Consistent with a role in facilitating
HR repair, we found that RNF169 also displayed a preference in
binding to RAD51-bound over RAD51-unbound DSBs (Fig. 2A).
CtIP Facilitates DNA End-Proximal Accumulation of RNF169. The
similar distribution patterns of RNF169 and HR factors CtIP,
RPA-1, and RAD51 at AsiSI-induced DSBs prompted us to
determine the genetic regulations for RNF169 deposition at
DSB-flanking chromatin (Fig. 2B). Although RNF169 distribu-
tion differed from that of RNF168 (SI Appendix, Fig. S8),
RNF169 enrichment at AsiSI-induced DSBs was hampered fol-
lowing small interference RNA (siRNA)-mediated inactivation
of RNF168, consistent with the requirement of the classical
RNF8/RNF168-mediated ubiquitination pathway in driving
RNF169 IRIF formation (SI Appendix, Fig. S9 A and B). The
observation that DSB distribution differed between RNF169 and
RNF168 may reflect the maturing of the damaged chromatin,
which drives the redistribution of DDR proteins along the
DSB-flanking chromatin domains. Given the established roles
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Fig. 2. Characterization of RNF169 end-proximal
distribution. (A) RNF169 preferentially loads on
RAD51-bound DSBs. DIvA-eRNF169 cells were treated
as in Fig. 1F. ChIP-qPCR analyses were performed
against γH2AX, RAD51, RPA-1, and Flag (eRNF169) at
RAD51-bound and RAD51-unbound DSBs. Box and
whisker plots are derived from one representative
experiment (n = 3) of three technical replicates.
**P < 0.01, ***P < 0.001. (B) Schematic illustrating
flow of experiment to define genetic requirement of
DSB end-proximal accumulation of eRNF169. (C and
D) CtIP promotes RNF169 accumulation at DSB end-
proximal regions. DIvA-eRNF169 cells pretreated
with indicated siRNAs were incubated with 1.0 μg/mL
doxycycline for 24 h. 4-OHT was added to cells for
4 h. Cells were subsequently processed for ChIP ex-
perimentations using anti-Flag antibodies (eRNF169).
qPCR analysis was performed to determine eRNF169
enrichments at Chr1_6 and Chr1_12. Data represents
mean ± SEM (of three technical repeats) derived
from one representative experiment (n = 3). *P <
0.05, **P < 0.01. (D) Western blotting experiment
was performed to assess RNAi-mediated CtIP knock-
down efficiency. (E) CtIP depletion impairs RNF169
accumulation at RAD51-bound DSBs. ChIP-qPCR ex-
perimentations and analyses were performed as in C.






tested whether the DNA end resection machineries may con-
tribute to RNF169 accumulation at the DSB-flanking chromatin.
To this end, we inactivated MRE11, NBS1, and RAD50 in-
dividually in DIvA-eRNF169 cells using the CRISPR/Cas9
method. ChIP of eRNF169 from MRN-inactivated cells did not
yield quantitative change to its accumulation at AsiSI-induced
DSBs compared with control (SI Appendix, Fig. S9 C and D),
despite robust interactions between the MRN complex and
RNF169 (SI Appendix, Fig. S9E). We also silenced CtIP using
two previously characterized CtIP-specific siRNAs (58, 59) and
examined RNF169 loading at the two AsiSI-induced DSBs (Fig.
2 C and D). Interestingly, we reproducibly observed a moderate
reduction in RNF169 loading at proximal chromatin regions
flanking each of the two DSBs (Fig. 2C). Moreover, accumu-
lation of RNF169 at RAD51-bound DSBs was similarly reduced
following CtIP silencing (Fig. 2E). On the contrary, ChIP
analysis of CtIP, MRE11, and NBS1 at AsiSI-induced DSBs
were indistinguishable in control and RNF169 KO cells (SI Ap-
pendix, Fig. S10 A–C). Taken together, we propose that CtIP fa-
cilitates RNF169 accumulation on chromatin domains proximal
to DSBs.
RNF169 Promotes DSB Resection. RNF169 enriched at DSB-
proximal regions (Fig. 1), accumulated at RAD51-bound DSBs
(Fig. 2), and promoted high-fidelity HR repair (47, 50). These
observations led us to examine whether RNF169 may be in-
volved in DSB resection. To this end, we quantitatively measured
the abundance of ssDNA intermediates at AsiSI-induced DSBs
following a previously described method (60). Briefly, genomic
DNA harvested from DIvA-eRNF169 cells following AsiSI in-
duction was pretreated with restriction enzymes (BsrGI or BanI)
to digest double-strand DNAs (Fig. 3A). The resulting DNA
preparations, including intact resected ssDNA intermediates,
were subjected to qPCR quantification. We focused our analysis
on two AsiSI target sites on Chromosome 1 (DSB-α) and Chro-
mosome 22 (DSB-β), both of which have been shown to undergo
robust DNA end resection (60–62), and assayed for ssDNA in-
termediates at three loci that span either the BsrGI (DSB-α) or
the BanI (DSB-β) restriction sites (Fig. 3A). We included an ir-
relevant site that spans a HindIII restriction site on Chromosome
22 as a negative control (No DSB; Fig. 3A).
Because DSB resection is activated during S/G2 cell cycle
phases, to increase DSB resection efficiency and the robustness
of ssDNA detection, we briefly arrested DIvA-eRNF169 cells at
S/G2 cell cycle phases using thymidine before 4-OHT treatment
(SI Appendix, Fig. S11A). Accordingly, AsiSI induction resulted
in a substantial increase in the abundance of ssDNA interme-
diates at both “DSB-α” and “DSB-β” sites, but not at the “No
DSB” site (Fig. 3 B and C). ssDNA intermediates were more
readily detected at DSB proximal regions, consistent with the
nature of DSB resection regulation (Fig. 3 B and C). Inactivation
of CtIP by siRNAs suppressed ssDNA generation, consistent
with its roles in initiation of DSB resection (63) (Fig. 3 B–D). We
further tested the effects of BRCA1 and EXO1 depletion on
ssDNA generation since both DDR factors are associated with
the DSB resection process (64, 65). Results showed that the
ssDNA generation was moderately but significantly decreased in
BRCA1-depleted or EXO1-depleted cells (Fig. 3 B–D). Notably,
RNF169 depletion by two independent previously characterized
siRNAs (48) similarly led to reduction in the abundance of
ssDNA intermediates at the AsiSI-induced DSB sites, indicating
that RNF169 may facilitate DSB end resection (Fig. 3 B–D). To
further corroborate this idea, we generated RNF169 knockout
(KO) AsiSI-ER-U2OS cells and found that level of ssDNA in-
termediates was also modestly reduced (SI Appendix, Fig. S11 B–
D). By contrast, deficiency of both 53BP1 and RAP80 re-
producibly led to increased abundance of ssDNA intermediates
(SI Appendix, Fig. S11 B–D), results that are in line with their
established roles in limiting DSB resection (24, 43, 45, 60). We
concluded that RNF169 promotes DSB end resection.
RNF169 Promotes Homology-Mediated DSB Repair.We next assessed
the roles of RNF169 in DSB repair using established cell reporters
that measure DSB repair events mediated by HR, SSA, and aNHEJ
and total NHEJ, respectively (66, 67). Because of the putative role
of RNF169 in facilitating DSB end resection (Fig. 3 B and C and SI
Appendix, Fig. S11 B and C), we speculated that RNF169 may be
specifically required for resection-dependent DSB repair, namely,
HR, SSA, and aNHEJ. Accordingly, the DSB repair reporter cells
harbor a disrupted GFP gene, and expression of intact GFP requires
successful repair of an I-SceI–induced DSB at the gene locus, and
can be quantified by flow cytometric analysis (Fig. 3 E–H, Top) (66).
We silenced RNF169 using two individual siRNAs (48), and found
that RNF169 inactivation compromised high-fidelity HR repair,
results that are entirely consistent with previously described (47, 50).
The core HR factor PALB2 served as a positive control (Fig. 3E).
Importantly, SSA and aNHEJ repair efficiencies were also signifi-
cantly reduced following RNF169 silencing, as were that in RAD52-
depleted and Polθ-depleted cells, which were used as positive con-
trols to assess SSA and aNHEJ, respectively (Fig. 3 F and G). By
contrast, we did not observe robust change in NHEJ repair effi-
ciency in RNF169 knockdown cells (Fig. 3H). Together, these data
suggested that RNF169 promotes (micro)homology-directed DSB
repair, consistent with its role in facilitating DSB resection.
RNF169 Dose-Dependently Regulates SSA Repair. Inspired by the
role of eRNF169 in limiting DSB deposition of 53BP1 and
RAP80, we tested whether forced expression of RNF169 may
overcome the 53BP1-imposed and RAP80-imposed barrier to
resection-dependent DSB repair processes. To this end, we
overexpressed RNF169 in the DSB repair reporter cells, and
surprisingly, found that RNF169 specifically stimulated SSA re-
pair (Fig. 4 A and B and SI Appendix, Fig. S12 A–C). RNF169-
driven SSA repair also required its MIU2 domain (Fig. 4 A and
B), suggesting that RNF169 promotes SSA by antagonizing
53BP1 and/or RAP80. Noting that 53BP1 KO cells also sup-
ported hyperactive SSA (Fig. 4 C and D) (68), we tested whether
53BP1 inactivation may reverse the stimulating effect of RNF169 on
SSA. Indeed, we found that the RNF169-stimulated SSA was largely
attenuated in 53BP1 KO cells (Fig. 4 E and F), indicating that
RNF169 promotes SSA, at least in part, by counteracting 53BP1.
We further examined whether 53BP1 deficiency may restore SSA
repair to normal levels in a RNF169-deficient background. Consis-
tent with the idea that the RNF169-53BP1 balance modulates SSA
repair, we found that coinactivation of RNF169 and 53BP1 restored
SSA to levels observed in otherwise wild-type control cells (Fig. 4 G
and H). It is noteworthy to mention that 53BP1 deficiency did not
alleviate the HR defects seen in RNF169 knockdown cells (SI Ap-
pendix, Fig. S13 A and B), highlighting a more specific role of
53BP1 in counteracting RNF169-dependent SSA repair.
RNF169 Stimulates SSA Repair in HR-Deficient Cells. Given that
53BP1 loss alleviates defects in DSB resection in BRCA cells
(35–37), our observation that RNF169 may regulate SSA repair
by counteracting 53BP1 activity led us to examine the regulation of
RNF169-driven SSA in BRCA1-deficient, BRCA2-deficient, and
PALB2-deficient cells. We therefore tested for a more specific role
of RNF169 in modulating SSA repair in BRCA-deficient back-
grounds. Accordingly, BRCA1 silencing impaired SSA (Fig. 5),
consistent with its roles in multiple steps of DSB resection and
DSB repair pathways (69). Inactivation of the core HR factor
BRCA2 and PALB2, however, resulted in hyperactive SSA (Fig. 5),
an observation that is in line with the competition between SSA and
HR (70, 71). Interestingly, consistent with its dose-dependent
stimulating effect on SSA repair, cells overexpressing RNF169
supported substantially elevated SSA in BRCA1-silenced, BRCA2-
silenced, and PALB2-silenced cells (Fig. 5 A and B), whereas in-
activation of RNF169 in BRCA2-silenced and PALB2-silenced
cells, but not BRCA1-deficient cells, led to marked reduction of
the otherwise hyperactivated SSA (Fig. 5 C and D). Together with
the observation where forced expression of RNF169 did not af-
fect HR repair in BRCA1, PALB2, or BRCA2 knockdown cells
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Fig. 3. RNF169 promotes DSB resection and homology-directed repairs. (A) Schematic for quantitative DNA resection assay based on the DIvA system.
(B and C) Quantitative measurement of ssDNA generation by 5′ end resection at two AsiSI-induced DSBs. DIvA cells pretreated with indicated siRNAs were
incubated with 4-OHT for 4 h. Genomic DNA was extracted and digested with either BsrGI (B) or BanI (C ). Percentage of ssDNA intermediates at indicated
sites was measured by qPCR using primers indicated in A after restriction enzyme digestion. Data represents mean ± SEM (of two technical repeats) from
three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001; ns, not significant. (D) Western blotting experiment was performed to assess RNAi-
mediated knockdown efficiency in cells used in B and C. (E–H) RNF169 deficiency impairs resection-dependent DSB repair. Schematic representation of the
DR-GFP, SA-GFP, EJ2-GFP, and EJ5-GFP reporters to analyze the repair of I-SceI-induced DSBs by HR, SSA, aNHEJ, and total NHEJ events (Top). U2OS cells
stably expressing DR-GFP (E ), SA-GFP (F ), EJ2-GFP (G) and EJ5-GFP (H) were transfected with indicated siRNAs and were electroporated with plasmid
encoding the I-SceI endonuclease. (Middle) Flow cytometric analysis of GFP-positive cell population was performed 48 h after electroporation. Data
represents mean ± SEM from three independent experiments, **P < 0.01, ***P < 0.001; ns, not significant. (Bottom) Knockdown efficiencies were de-
termined by Western blotting.






(SI Appendix, Fig. S13 C and D), our findings suggest that RNF169
specifically fine-tunes SSA repair in BRCA cells.
Role of RAP80 in RNF169-Dependent DSB Repair. Our ChIP profiling
and superresolution imaging experimentations revealed overlapping
distribution of RNF169 and RAP80 at DSB-flanking chromatin
domains (Fig. 1 C and F). In addition to its documented roles in
restricting DSB resection (42, 43), RAP80 knockdown cells also
displayed hyperactive HR and SSA repair (41, 43–45). Because
eRNF169 also limited RAP80 deposition at DSBs (SI Appendix,
Figs. S2B and S5A), we studied the antagonistic relationships be-
tween RNF169 and RAP80 in DSB repair control. We inactivated
RAP80 using two independent RAP80-targeting gRNAs (72) and
found that RAP80 deficiency coincided with hyperactive HR, SSA,
and aNHEJ repair (SI Appendix, Fig. S14 A–C). Importantly, inac-
tivation of RNF169 partially but significantly dampened HR, SSA,
and aNHEJ repair in RAP80 null cells (SI Appendix, Fig. S14 A–C).
Because both 53BP1 and RAP80 limits DSB end resection, and that
forced expression of RNF169 specifically promoted SSA repair (Fig.
4A), we examined whether the RNF169-driven SSA may be atten-
uated in cells deficient in both 53BP1 and RAP80. Consistently, we
found that cells inactivated for both RAP80 and 53BP1 effectively
suppressed the stimulating effect of RNF169 in SSA (SI Appendix,
Fig. S14 D and E), revealing a complex interplay between RNF169
and 53BP1/RAP80 in DSB repair control.
Discussion
The RING finger protein RNF169 counteracts the loading of
DNA damage mediator proteins 53BP1 and RAP80 onto DSBs
and has emerged as a negative regulator in DSB signal trans-
duction (47–49). However, exactly how RNF169 fine-tunes 53BP1
and RAP80 activities to execute DSB repair has remained un-
known. On the basis of the RNF169-encoded antagonism of
53BP1 and RAP80, our observations that dosage imbalance of
RNF169 dysregulates DSB resection and choice of DSB repair
pathways suggest that RNF169 may skew DSB repair pathways, at
least in part, by restraining 53BP1-dependent and RAP80-
dependent signal amplification. Indeed, the notion that DSB sig-
nal output, including the extent of DSB ubiquitylation, plays a
determining role in choice of DSB repair in not unprecedented
(73, 74). Previous work has identified OTUB2 as a negative reg-
ulator of the core ubiquitin ligase RNF8, where it suppresses
RNF8 activity to promote high-fidelity HR repair (75). The im-
portance of maintaining optimal RNF8 output was also unveiled
recently with the identification of the E3/E4 ligase UBE4A, which
enforces DSB signal output to promote optimal DSB resection
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Fig. 5. RNF169 stimulates SSA repair in HR-deficient cells. (A and B) Ectopic
expression of RNF169 stimulates SSA repair in BRCA1-deficient, PALB2-
deficient, and BRCA2-deficient cells. SA-U2OS-eRNF169 cells pretreated
with indicated siRNAs were treated and processed as described in Fig. 4A.
Data represents mean ± SEM from four independent experiments, **P <
0.01, ***P < 0.001. (B) Western blotting experiment was performed to assess
RNAi-mediated knockdown efficiencies. (C and D) RNF169 is required for
hyperactive SSA in PALB2-deficient and BRCA2-deficient cells. SA-U2OS cells
were transfected with indicated siRNAs and processed as described in Fig. 4C.
Data represents mean ± SEM from four independent experiments, *P < 0.05,
***P < 0.001; ns, not significant. (D) Western blotting experiment was per-
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Fig. 4. RNF169 stimulates SSA repair by counteracting 53BP1. (A) Ectopic
expression of RNF169 but not RNF169MIU2 stimulates SSA repair. SA-U2OS-
eRNF169 or SA-U2OS-eRNF169ΔMIU2 cells were electroporated with plasmid
encoding the I-SceI endonuclease. Cells were cultured with or without 2 μg/mL
doxycycline for 48 h before cells were harvested for flow cytometric
analysis. Mock electroporation (no I-SceI) was used as negative control. Data
represents mean ± SEM from three independent experiments, ***P < 0.001,
ns, not significant. (B) Western blotting analysis showing expression of
RNF169 (wild-type and ΔMIU2 mutant). (C) 53BP1 inactivation promotes SSA
repair. SA-U2OS (vector control and 53BP1 KO) cells were electroporated
with I-SceI expression construct and percentage of cells positive for GFP was
analyzed 48 h after electroporation. Data represents mean ± SEM from
three independent experiments, ***P < 0.001. (D) Western blotting analysis
to determine 53BP1 expression. (E) RNF169-driven SSA repair was alleviated
in 53BP1 KO cells. Parental SA-U2OS-eRNF169 cells (Vector) or its 53BP1 KO
derivative were treated and processed as described in A. Data represents
mean ± SEM from three independent experiments, *P < 0.05, ***P < 0.001.
(F) Western blotting analysis to determine RNF169 expression in cells used in
E. (G) 53BP1 deficiency restores SSA repair in RNF169-inactivated cells. Pa-
rental SA-U2OS cells (Vector) or its 53BP1 KO derivative were transfected
with indicated siRNAs. Cells were treated and processed as described in C.
Data represents mean ± SEM from three independent experiments, **P <
0.01. (H) Western blotting analysis was performed to assess RNAi-mediated
knockdown efficiency in cells used in G.
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may have additional roles in DSB response control, our data adds
an additional regulatory layer of DSB signal output and firmly
establish the interplay of RNF169 and 53BP1/RAP80 as active
regulators of DSB repair pathway choice.
Current evidence suggests that both RNF169 and 53BP1 rec-
ognize and compete for H2AK15ub-containing nucleosomes at
DSBs, with RNF169 bearing higher affinity for the ubiquitin
conjugate in vitro (21, 51, 52). However, exactly how the two
competing activities engage in a dynamic interplay at the dam-
aged chromatin is not clear. By recapitulating the dynamic an-
tagonisms of RNF169 and 53BP1 at IRIFs in the DIvA platform
(SI Appendix, Figs. S2 A and B and S5A), we employed super-
resolution imaging to capture RNF169 and 53BP1 at AsiSI-
induced DSBs and have revealed that RNF169 is oriented
juxtaposed to 53BP1 (Fig. 1 B and D), an observation supported
by our ChIP experimentations (Fig. 1F). Interestingly, ChIP pro-
filing of RNF169 and 53BP1 at AsiSI-induced DSBs not only
indicates that RNF169 and 53BP1 exhibit dissimilar distributions
at the DSB-flanking chromatin, but also revealed that RNF169
preferentially accumulates at chromatin territories proximal to
the DSBs, raising the possibility that RNF169 may contribute to
the early processing of DSBs. In support of this idea, we found
that RNF169 inactivation attenuated DSB end resection (Fig. 3
B–D and SI Appendix, Fig. S11 B–D) and led to impaired DSB
repair via the HR, SSA, and aNHEJ pathways (Fig. 3 E–G). The
fact that forced expression of RNF169-stimulated SSA repair
(Figs. 4 A and E and 5A) but not HR or aNHEJ (SI Appendix,
Figs. S9 A and B and S13C) suggests that DSB processing, es-
pecially that involving long-range DNA resection, may be more
dependent on the homeostatic balance of RNF169 and 53BP1 at
DSBs. This idea is supported by the observation that RNF169
silencing, much like inactivation of EXO1, did not noticeably
affect CPT-induced RPA-1 foci detected by indirect immuno-
fluorescence studies (SI Appendix, Fig. S15 A–C). Moreover,
dosage imbalance of RNF169 also did not dysregulate focal ac-
cumulation nor chromatin distribution of BRCA1 and RAD51 at
AsiSI-induced DSBs (SI Appendix, Fig. S16 A–C). Considering
that 53BP1 prevents hyperresection to foster high-fidelity DSB
repair (39), and that 53BP1 deficiency attenuated RNF169-
driven SSA (Fig. 4E), our findings highlight the importance of
a fine balance of RNF169 and 53BP1 in proper choice of DSB
repair pathways, and that RNF169 amplification may contribute
to genome instability in human cancers (SI Appendix, Fig. S17).
Unlike the established competition between RNF169 and
53BP1 for H2AK15ub (21, 51, 52), exactly how RNF169 dis-
places RAP80 from DSBs is less clear. Since RNF168 promotes
its own DSB recruitment by interacting with H2AK15ub (49, 51,
52), one can envisage that RNF169 may compete with RNF168
for H2AK15ub-containing nucleosomes, thereby suppressing the
RNF168-dependent RAP80 recruitment onto the damaged
chromatin. Alternatively, that RAP80 is targeted to DSBs via its
ability to interact with both SUMO-linked and K63-linked
ubiquitin polymers (77–81) raises the possibility that RNF169
may bind to additional but heretofore unidentified targets at
DNA end-proximal regions surrounding DSBs, given our ob-
servations that RNF169 and RAP80 exhibit similar distribution
patterns along chromatin domains that flank DSBs (Fig. 1F).
Intriguingly, although RNF169 docks at IRIFs and AsiSI-induced
DSBs in manners that strictly require its ubiquitin-binding
MIU2 domain and the primary DSB ubiquitin ligases RNF8 and
RNF168 (47–49) (SI Appendix, Figs. S2D, S5B, and S9 A and B),
we found that CtIP inactivation specifically attenuated RNF169
accrual at chromatin domains proximal to DSBs (Fig. 2 C–E).
Considering that RNF169 interacts with the MRN complex (SI
Appendix, Fig. S9E), and that RNF169 promotes DSB end re-
section (Fig. 3 B–D and SI Appendix, Fig. S11 B–D), it is tempting
to speculate that the MRN/CtIP-RNF169 complex may contribute
to the optimal processing of DNA ends. Although further ex-
perimentations will be required to clearly define how the MRN/
CtIP-RNF169 axis contributes to optimal DNA resection, our
work suggests that RNF169 shunts DSBs to resection-dependent
repair, and that aberrant RNF169 expression may upset proper
DSB repair pathway choice and contribute to chromosomal in-
stability (SI Appendix, Fig. S18 A–C).
While the tumor suppressor BRCA1 may participate in mul-
tiple DSB repair pathways (69), consistent with previous reports
(70, 82–84), we found that inactivation of the core HR factor
PALB2 and BRCA2 led to substantially elevated SSA (Fig. 5),
highlighting the complex and competitive nature of HR and
SSA. Our observation is in line with the competing nature of the
resection-dependent DSB repair pathways, where inactivation of
HR machineries, including BRCA2 and RAD51, has been
reported to fuel aNHEJ and SSA (82, 83, 85). Importantly,
RNF169 promoted SSA in both PALB2 and BRCA2 proficient
and deficient backgrounds (Fig. 5), highlighting an unprecedented
role of RNF169 as an SSA factor. Because SSA plays an impor-
tant role in mending DNA DSBs at repetitive DNA loci, noting
the increased repetitive nature of higher eukaryotic genomes, it
would be of significant interest to explore how RNF169 may have
evolved as an RNF168 paralogue, how RNF169 supports RAD52
accumulation at DSBs (SI Appendix, Fig. S19), and how RNF169
expression levels correlate with stability and integrity of repetitive
genomic loci. In summary, our findings uncovered the interplay of
RNF169 and 53BP1 in SSA regulation, illuminate how a molec-
ular rheostat of DSB response output contributes to DSB repair
control, and implicate RNF169 as a key component in the
mammalian DDR network that safeguards genome stability in
higher eukaryotes (SI Appendix, Fig. S20).
Materials and Methods
Cell Cultures. AsiSI-ER-U2OS cells were cultured in DMEM supplemented with
10% FBS and 1 μg/mL puromycin at 37 °C in 5% CO2. For AsiSI-dependent
DSB induction, cells were treated with 600 nM 4-OHT (H7904; Sigma) for 4 h.
The four DSB repair reporter cell lines (EJ2-U2OS, DR-U2OS, SA-U2OS, and
EJ5-U2OS) were cultured in DMEM supplemented with 10% FBS and were
previously described (66). For generation of cell lines with doxycycline-
inducible expression of RNF169 (WT and ΔMIU2), the RNF169 cDNA was
cloned in frame 3′ of the SFB (S protein, Flag, and Streptavidin-binding
peptide) sequence. Cells (DIvA and the four reporter cell lines) were in-
fected with lentiviral particles carrying RNF169 (WT and ΔMIU2)-SFB ex-
pression constructs and were subsequently selected by 2 mg/mL G418 for
1 wk. Expression of RNF169-SFB was induced by supplementing cell culture
media with doxycycline (D9891; Sigma).
Generation of KO Cells by Use of the CRISPR/Cas9 Method. All KO cell lines
(DIvA, DR-U2OS, and SA-U2OS) used in this study were generated using the
CRISPR-Cas9 gene targeting approach. All of the guide RNAs (gRNAs) used in
this study were cloned into the pLentiCRISPR v2 vectors and their sequences
were as follows: MRE11 gRNA: 5′-AGTAACAATGTTGAGACCAA-3′; RAD50 gRNA:
5′-TTAAAGCCTTAGAAACACTT-3′; NBS1 gRNA: 5′-ACTGGCGTTGAGTACGTTGT-
3′; RNF169 gRNA: 5′-CTGCCGCCGTCTCGTCACAG-3′; 53BP1 gRNA: 5′-CAGAAT-
CATCCTCTAGAACC-3′; RAP80 gRNA1#: 5′-GTCGAATAGAGCAAAGTGTT-3′; RAP80
gRNA2#: 5′-GAAGAAATCACTGTTTGTCC-3′. For generation of KOs, cells were in-
fected with lentiviral particles harboring each gRNAs twice at 24-h intervals. KO
cells were allowed to grow for 1 wk before validation by Western blotting.
Lentivirus Packaging and Infection. Lentiviral particles were produced by
transiently cotransfecting the lentiviral-based expression constructs together
with packaging plasmids psPAX2 and pMD2.G at a ratio of 4:3:1 into
HEK293T cells. Forty-eight hours after transfection, the supernatants were
filtered (0.45 μm) and were applied to recipient cell lines in the presence of
8 μg/mL polybrene (Sigma).
RNA Interference. For RNAi-mediated depletion experiments, cells were
transfected with two rounds of either nontargeting control or targeting
siRNAs (Dharmacon) using Oligofectamine (Invitrogen). siRNAs against
RNF168 were previously described (86, 87). Other target genes and their
siRNA sequences are as follows: Control siRNA: 5′-UAGCGACUAAACACAU-
CAA-3′, RNF169 siRNA-1#: 5′-GAGCCAGACUUUAUAUUCA-3′, RNF169 siRNA-
2#: 5′-GCAUCUCCGAAGAACUAAA-3′, CtIP siRNA-1#, 5′-UCCACAACAUAA-
UCCUAAU-3′; CtIP siRNA-2#, 5′-AAGCUAAAACAGGAACGAAUC-3′; PALB2 siRNA:
5′-GCAUAAACAUUCCGUCGAA-3′; RAD52 siRNA: 5′-GGAGUGACUCAAGAAUUAA-3′;
DNA Ligase IV siRNA: 5′-AAGCCAGACAAAAGAGGUGAA-3′; Polθ siRNA: 5′-
AGCUUCCACUCCUAGAAGGGA-3′; BRCA1 siRNA: 5′-GGAACCTGTCTCCACAAAG-3′;






BRCA2: 5′-GAAGAAUGCAGGUUUAAU-3′; EXO1 siRNA-1: 5-GAAGUUUCGUU-
ACAUGUGU-3; EXO1 siRNA-2: 5- GUAAAUGGACCUACUAACA-3; EXO1 siRNA-3:
5-ACUCGGAUCUCCUAGCUUU-3; EXO1 siRNA-4: 5-GUUAGCAGCAUUUGGCAUA-
3. For EXO1 depletion the four siRNAs were used as a pool.
Antibodies. Antibodies used for immunofluorescence staining, Western
blotting, and ChIP are listed in SI Appendix, Table S1.
Immunofluorescence Staining. Cells grown on coverslips were fixed with 3%
paraformaldehyde for 15 min at room temperature followed by per-
meabilization in 0.5% Triton solution for 30 s. A preextraction step was used
when necessary and involved cell premeabilization in Triton solution for 30 s
before fixation. After blockingwith 3%milk at room temperature for 20min,
cells were stained by sequential incubation of primary antibodies and sec-
ondary fluorophore-conjugated antibodies (SI Appendix, Table S1). DAPI was
used to stain nuclear DNA. Images were captured using a 60× oil immersion
lens on an Olympus BX51 fluorescence microscope and were further pro-
cessed by ImageJ software.
Superresolution Fluorescence Microscopy. SR-SIM imaging was performed on a
Zeiss Elyra S1 microscope with 100× oil immersion lens (N.A. = 1.46). Z-stack
images with 0.1 μm per step were taken between 1 and 2 μm over the glass
substrate. SR-SIM images were reconstructed by ZEISS Efficient Navigation
(ZEN) 2012 software, and maximum projection of the entire 1-μm volume
was processed by ImageJ software. Dual-color STORM images were acquired
by a SRiS (STORM) Super-Resolution Microscope (Nano BioImaging) and
processed by QuickPALM in ImageJ, as previously described (88).
ChIP. ChIP was performed based on a protocol previously described with
minor modifications (89). Briefly, cells were cross-linked with formaldehyde
(1.42%) for 15 min at room temperature. Cross-linking was quenched by the
addition of glycine (125 mM) for 5 min. Cells were washed twice with cold
PBS and collected by scraping. Pelleted cells were resuspended in 300 μL of
lysis buffer (50 mM Hepes/KOH, pH 7.5; 50 mM Hepes/KOH, pH 7.5; 140 mM
NaCl; 1 mM EDTA; 1% Triton X-100; 0.1% Na-deoxycholate and protease in-
hibitors). To shear the chromatin, cells were sonicated with Bioruptor for 18 cy-
cles (high power, 30 s on and 30 s off). After sonication, samples were diluted
twice in lysis buffer and were subsequently centrifuged to clear the supernatant.
Fifty microliters of supernatant were directly processed to extract total DNA as
whole cell input. The remaining supernatants were transferred to new Eppen-
dorf tubes and were incubated with indicated antibodies (SI Appendix, Table S1)
together with prewashed protein A beads (16–157; Millipore) at 4 °C overnight.
Beads were washed five times with indicated buffers and were mixed with
100 μL of 10% chelex (1421253; Bio-Rad). The samples were boiled for 10 min
and centrifuged at 4 °C for 1 min. Supernatants were transferred to new tubes.
After that, another 120 μL ofMilliQ water was added to each beads pellet, vortex
for 10 s, and were centrifuged again to spin down the beads. Combine the
supernatants together as templates for follow-up qPCR analysis.
Real-Time qPCR Analysis. PCR analysis was performed on aMyiQ2 Real Time PCR
Detection System (Bio-Rad) using the iTaq SYBR Green Supermix (172–5124; Bio-
Rad), according to the manufacturer’s instructions. All samples were analyzed in
duplicates. The IP efficiency was calculated as percent of input for DNA
immunoprecipitated. Primer sequences used for profiling protein distribution at
Chr1_6 and Chr1_12 were listed in SI Appendix, Table S2. Primers used for qPCR
analysis at RAD51-bound and RAD51-unbound DSBs were described (54).
Western Blotting. Cells were scraped in PBS, pelleted, and lysed in NETN buffer
(20 mM Tris·HCl, pH 8.0, 100 mM NaCl, 0.5% Nonidet P-40, and 1 mM EDTA)
supplemented with BitNuclease (Biotool) on ice for 15 min. Cell lysates were
boiled after addition of Lamelli buffer. Proteins were separated by SDS/PAGE,
transferred to PVDF membranes, which were then incubated with indicated
primary and secondary antibodies (SI Appendix, Table S1).
In Vivo DNA End Resection Assay. Briefly, DIvA cells were treated with or
without 600 nM 4-OHT for 4 h to induce AsiSI-dependent DSBs. Thereafter,
genomic DNA was purified using the standard phenol-chloroform extraction
method. For each sample, around 300 ng of extracted DNA was subjected to
an RNase H treatment for 15 min before mock digestion or digestion with
20 units of BsrGI (DSB-α)/BanI (DSB-β)/HindIII (No DSB) at 37 °C overnight.
Samples were heat-inactivated at 65 °C for 10 min and were analyzed by
qPCR. To quantify the extent of resection, around 20 ng (2 μL) of mock
digested or indicated restriction enzyme digested samples were amplified by
qPCR using primers listed in SI Appendix, Table S3. The percentage of ssDNA
(ssDNA %) was calculated based on the following equation: ssDNA % =
1/(2Ct−1 + 0.5) × 100. Ct was calculated by subtracting the Ct value of the
mock-digested sample from the Ct value of indicated restriction enzyme
digestion sample. At least three biological repeats were performed.
Cell Cycle Analysis. To collect cells in different cell cycle phases, cells were
treated with L-mimosine (M0253; Sigma) for 24 h to arrest cells in G1 phase. S
and G2 phase cells were collected 7 h and 15 h upon mimosine release, re-
spectively. To directly collect S/G2 cell populations, cells were treated with
2 mM thymidine for 18 h and further released for 4 h before harvest. Cells
were trypsinized and fixed with drop-wise addition of ice-cold 70% ethanol.
After overnight incubation at −20 °C, fixed cells were washed once with PBS
and were treated with 200 μL of sodium citrate solution containing RNase A
for 30 min at room temperature followed by addition of another 200 μL of
sodium citrate solution containing 50 μg/mL propidium iodide. Cell-cycle
distribution was determined using a BD FACS CantoII Analyzer.
DSB Repair Analysis in the HR, cNHEJ, SSA, and aNHEJ Reporter Cell Lines. U2OS
cells stably expressing DR-GFP (DR-U2OS), EJ5-GFP (EJ5-U2OS), SSA-GFP (SSA-
U2OS), and EJ2-GFP (EJ2-U2OS) (67) were transfected with indicated siRNAs
and electroporated with the I-SceI expression construct (pCBASce) at 200 V,
975 microfarads using Gene Pulser XCell (Bio-Rad). Cells were further re-
covered for 48 h after electroporation and were subjected to for flow
cytometric analysis using a BD FACS CantoII Analyzer.
Statistical Analysis. Unless otherwise stated, data represent mean ± SEM of at
least three independent experiments. Student’s t test (two-tailed) was used to
evaluate statistical significance, and a P < 0.05 value was considered as significant.
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